Study protocol
Rationale and design of a double-blind, placebo-controlled, randomized trial to evaluate the safety and efficacy of nimodipine in preventing cognitive impairment in ischemic cerebrovascular events (NICE)
Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
BMC Neurology 2012, 12:88 doi:10.1186/1471-2377-12-88
Published: 5 September 2012Additional files
Additional file 1:
Appendix.
Format: DOC Size: 27KB Download file
This file can be viewed with: Microsoft Word Viewer


